OPKO Health (OPK)
(Real Time Quote from BATS)
$1.61 USD
0.00 (0.00%)
Updated Feb 6, 2025 03:34 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Balance Sheet
Fiscal Year End for OPKO Health, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 96 | 153 | 135 | 72 |
Receivables | NA | 123 | 127 | 260 | 286 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 66 | 74 | 87 | 132 |
Other Current Assets | NA | 25 | 40 | 342 | 32 |
Total Current Assets | NA | 309 | 395 | 823 | 523 |
Net Property & Equipment | NA | 75 | 83 | 80 | 141 |
Investments & Advances | NA | 16 | 28 | 11 | 16 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 1,339 | 1,419 | 842 | 1,156 |
Deposits & Other Assets | NA | 204 | 204 | 600 | 600 |
Total Assets | NA | 2,012 | 2,167 | 2,400 | 2,473 |
Liabilities & Shareholders Equity | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 70 | 67 | 276 | 101 |
Current Portion Long-Term Debt | NA | 27 | 37 | 0 | 25 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 90 | 98 | 0 | 241 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 43 | 0 |
Total Current Liabilities | NA | 200 | 213 | 330 | 375 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 127 | 126 | 148 | 137 |
Convertible Debt | NA | 214 | 210 | 188 | 222 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 27 | 27 | 15 | 37 |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 622 | 606 | 715 | 802 |
Shareholders Equity | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 8 | 8 | 7 | 7 |
Capital Surplus | NA | 3,433 | 3,422 | 3,222 | 3,153 |
Retained Earnings | NA | -2,012 | -1,823 | -1,512 | -1,482 |
Other Equity | NA | -38 | -43 | -31 | -4 |
Treasury Stock | NA | 2 | 2 | 2 | 2 |
Total Shareholder's Equity | NA | 1,389 | 1,562 | 1,685 | 1,672 |
Total Liabilities & Shareholder's Equity | NA | 2,012 | 2,167 | 2,400 | 2,473 |
Total Common Equity | 0 | 1,389 | 1,562 | 1,685 | 1,672 |
Shares Outstanding | 682.40 | 773.20 | 772.60 | 681.30 | 670.00 |
Book Value Per Share | 0.00 | 1.80 | 2.02 | 2.47 | 2.49 |
Fiscal Year End for OPKO Health, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 406 | 41 | 76 | 96 |
Receivables | NA | 107 | 105 | 111 | 123 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 59 | 60 | 59 | 66 |
Other Current Assets | NA | 57 | 152 | 145 | 25 |
Total Current Assets | NA | 630 | 358 | 391 | 309 |
Net Property & Equipment | NA | 72 | 67 | 64 | 75 |
Investments & Advances | NA | 101 | 101 | 41 | 16 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 1,177 | 1,189 | 1,211 | 1,339 |
Deposits & Other Assets | NA | 214 | 203 | 204 | 204 |
Total Assets | NA | 2,256 | 1,980 | 1,974 | 2,012 |
Liabilities & Shareholders Equity | 12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 13 | 0 | 23 | 0 |
Accounts Payable | NA | 63 | 82 | 71 | 70 |
Current Portion Long-Term Debt | NA | 0 | 22 | 0 | 27 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 123 | 95 | 89 | 90 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 9 | 10 | 0 |
Total Current Liabilities | NA | 212 | 220 | 204 | 200 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 128 | 119 | 122 | 127 |
Convertible Debt | NA | 179 | 176 | 323 | 214 |
Long-Term Debt | NA | 245 | 0 | 21 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 20 | 0 | 27 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 853 | 585 | 721 | 622 |
Shareholders Equity | 12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 7 | 7 | 7 | 8 |
Capital Surplus | NA | 3,517 | 3,540 | 3,386 | 3,433 |
Retained Earnings | NA | -2,079 | -2,104 | -2,094 | -2,012 |
Other Equity | NA | -40 | -47 | -45 | -38 |
Treasury Stock | NA | 2 | 2 | 2 | 2 |
Total Shareholder's Equity | NA | 1,403 | 1,395 | 1,253 | 1,389 |
Total Liabilities & Shareholder's Equity | NA | 2,256 | 1,980 | 1,974 | 2,012 |
Total Common Equity | 0 | 1,403 | 1,395 | 1,253 | 1,389 |
Shares Outstanding | 682.40 | 697.30 | 696.90 | 696.90 | 773.20 |
Book Value Per Share | 0.00 | 2.01 | 2.00 | 1.80 | 1.80 |